In this multicenter, randomized, controlled phase III trial, 412 patients were randomly assigned to two groups. One group was given minocycline in escalating doses of up to 400 mg per day for 9 ...

Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...

Furthermore, we showed that neuronal apoptosis is increased in the diabetic retina, as measured by caspase-3 activity. Minocycline represses diabetes-induced inflammatory cytokine production ...

score of 3 or 4, indicating moderate or severe disease. At 16 weeks, a higher proportion of patients in the minocycline ...